The global market for kidney stone management devices is projected to nearly double from USD 2.8 billion in 2023 to USD 5.1 billion by 2033, signaling a major healthcare investment opportunity, according to Coherent Market Insights. The market's projected near-doubling signals a period of strong growth in the kidney stone management device market. Patients requiring treatment for kidney stones will benefit from advanced technologies as the industry evolves to meet rising demand.
But the market is clearly growing rapidly, yet different analyses present significantly varied compound annual growth rates, indicating a lack of consensus on the precise pace of expansion. Technavio forecasts a 4.5% CAGR between 2023 and 2028, significantly lower than the 9.1% projected by Coherent Market Insights.
Companies and investors should carefully evaluate the underlying assumptions of market forecasts to accurately gauge investment risks and opportunities in this expanding medical device sector.
- The global kidney stone management devices market size is estimated to be valued at USD 2.8 billion in 2023.
- The market is expected to reach USD 5.1 billion by 2033, according to Coherent Market Insights.
- A compound annual growth rate (CAGR) of 9.1% from 2023 to 2033 is projected by Coherent Market Insights.
- Ureteroscopy procedures have success rates reaching up to 95%, according to Technavio (data from 2023-2028 forecast period).
- The shift toward single-use devices has been particularly prominent in hospitals across North America and Asia Pacific by late 2023 and Asia Pacific by late 2025, notes Coherent Market Insights.
- The ESWL device segment maintains dominance with 36% industry share, according to Coherent Market Insights (data from 2023-2033 forecast period).
- Asia is estimated to contribute 34% to the growth of the global market during the forecast period, according to Technavio.
Procedural Advancements Drive Market Evolution
Ureteroscopy procedures boast success rates reaching up to 95%, positioning them as a highly effective treatment option for kidney stones. The high efficacy of ureteroscopy procedures drives increased adoption of advanced devices within the market. The shift toward single-use devices has been particularly prominent in hospitals across North America and Asia Pacific by late 2025, indicating a preference for sterile, efficient tools.
The growing preference for single-use ureteroscopy devices, combined with superior clinical outcomes, is a key factor shaping the market's technological evolution. Manufacturers are responding to this trend by innovating new disposable instruments, impacting product development strategies.
Market Dynamics and Regional Contributions
The ESWL device segment currently maintains dominance with a 36% industry share, despite the higher success rates observed with ureteroscopy. Established technologies still hold a significant portion of the market, even as more effective alternatives gain traction. The kidney stones management devices market is expected to grow at a CAGR of 4.5% between 2023 and 2028, as forecasted by Technavio, contrasting with Coherent Market Insights' higher projection of 9.1%.
The discrepancy in growth forecasts highlights different interpretations of market velocity and technology adoption. Asia is estimated to contribute a substantial 34% to the growth of the global market during the forecast period, making it a crucial region for future investment and market penetration.
Strategic Imperatives for Device Manufacturers
Companies still heavily invested in ESWL technology, which currently dominates with 36% market share according to Coherent Market Insights (data from 2023-2033 forecast period), are facing an existential threat from the superior 95% success rates of ureteroscopy procedures highlighted by Technavio, demanding immediate R&D pivot or strategic acquisition. Given Asia's projected 34% contribution to market growth from Technavio and its early adoption of single-use devices observed by Coherent Market Insights (data from 2023-2025) single-use devices observed by Coherent Market Insights, manufacturers failing to prioritize and localize their single-use ureteroscopy offerings for this region are ceding critical future market leadership. The stark difference in CAGR projections—9.1% from Coherent Market Insights (2023-2033) versus 4.5% from Technavio (2023-2028)—signals that the kidney stone management market is not a uniform growth story, but rather a fragmented landscape where only those betting on the right technological shifts, like single-use URS, will realize the higher-end growth. By 2033, device manufacturers that have not significantly diversified their portfolios away from traditional ESWL technology and towards single-use ureteroscopy will likely see their market share erode significantly.
